Dr. Monica Mita is a specialist in medical oncology in Los Angeles, California and she is working in collaboration with many regional hospitals, such as Cedars-Sinai Medical Center and UCLA Medical Center Santa Monica. She got his diploma from Carol Davila University of Medicine and Pharmacy. She did a fellowship in hematology/oncology at University of Texas Health Science Center. The doctor has been practicing for more than 20 years.
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.
Sarantopoulos, J.,Mita, M. M.,Birrer, M. J.,Cranmer, L. D.,Campos, L. T.,Zhang, X.,Bristow, P.,Kaito, H.,Strout, V.,Camacho, L. H.; Target Oncol. 2015 Oct 29.
Dr. Monica Mita is a specialist in medical oncology in Los Angeles, California and she is working in collaboration with many regional hospitals, such as Cedars-Sinai Medical Center and UCLA Medical Center Santa Monica. She got his diploma from Carol Davila University of Medicine and Pharmacy. She did a fellowship in hematology/oncology at University of Texas Health Science Center. The doctor has been practicing for more than 20 years.
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.
Sarantopoulos, J.,Mita, M. M.,Birrer, M. J.,Cranmer, L. D.,Campos, L. T.,Zhang, X.,Bristow, P.,Kaito, H.,Strout, V.,Camacho, L. H.; Target Oncol. 2015 Oct 29.